Harmony Biosciences (HRMY) News
NASDAQ: HRMYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
40.28+0.68 (+1.72%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
HRMY news summary
We found 1 recent headline mentioning Harmony Biosciences (HRMY): 0 in the past week and 0 in the past 30 days, most often from Nasdaq. For price context, HRMY is up 1.72% at $40.28. The most recent story, "Weekly Buzz: RARE, REGN Secure FDA Nod, BMRN Stikes Deal; HUMA, EYPT Face Trial Setbacks", was published by Nasdaq on Aug 21, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology